An analysis of the root causes for opioid-related overdose deaths in the United States.

OBJECTIVE A panel of experts in pain medicine and public policy convened to examine root causes and risk factors for opioid-related poisoning deaths and to propose recommendations to reduce death rates. METHODS Panelists reviewed results from a search of PubMed and state and federal government sources to assess frequency, demographics, and risk factors for opioid-related overdose deaths over the past decade. They also reviewed results from a Utah Department of Health study and a summary of malpractice lawsuits involving opioid-related deaths. RESULTS National data demonstrate a pattern of increasing opioid-related overdose deaths beginning in the early 2000s. A high proportion of methadone-related deaths was noted. Although methadone represented less than 5% of opioid prescriptions dispensed, one third of opioid-related deaths nationwide implicated methadone. Root causes identified by the panel were physician error due to knowledge deficits, patient non-adherence to the prescribed medication regimen, unanticipated medical and mental health comorbidities, including substance use disorders, and payer policies that mandate methadone as first-line therapy. Other likely contributors to all opioid-related deaths were the presence of additional central nervous system-depressant drugs (e.g., alcohol, benzodiazepines, and antidepressants) and sleep-disordered breathing. CONCLUSIONS Causes of opioid-related deaths are multifactorial, so solutions must address prescriber behaviors, patient contributory factors, nonmedical use patterns, and systemic failures. Clinical strategies to reduce opioid-related mortality should be empirically tested, should not reduce access to needed therapies, should address risk from methadone as well as other opioids, and should be incorporated into any risk evaluation and mitigation strategies enacted by regulators.

[1]  L. Taylor,et al.  The definition of opioid-related deaths in Australia: implications for surveillance and policy. , 2005, Drug and alcohol review.

[2]  D. Nutt,et al.  Does alcohol increase the risk of overdose death: the need for a translational approach. , 2008, Addiction.

[3]  C. Argoff Clinical Implications of Opioid Pharmacogenetics , 2010, The Clinical journal of pain.

[4]  L. Manchikanti,et al.  Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. , 2007, Journal of opioid management.

[5]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[6]  Andrew A Somogyi,et al.  Pharmacogenetics of Opioids , 2007, Clinical pharmacology and therapeutics.

[7]  R. Portenoy,et al.  Establishing "best practices" for opioid rotation: conclusions of an expert panel. , 2009, Journal of pain and symptom management.

[8]  J. Gerberding,et al.  Unintentional poisoning deaths--United States, 1999-2004. , 2007, MMWR. Morbidity and mortality weekly report.

[9]  T. Buclin,et al.  Interindividual Variability of the Clinical Pharmacokinetics of Methadone , 2002, Clinical pharmacokinetics.

[10]  K. Furu,et al.  Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women. , 2010, Pain medicine.

[11]  K. Wells,et al.  Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? , 2007, Pain medicine.

[12]  Li Hui Chen,et al.  Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. , 2009, NCHS data brief.

[13]  David Wang,et al.  Sleep-disordered breathing with chronic opioid use , 2007, Expert opinion on drug safety.

[14]  H. Thaler,et al.  QTc interval prolongation associated with intravenous methadone , 2003, Pain.

[15]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[16]  K. Bain,et al.  A systematic review of opioid conversion ratios used with methadone for the treatment of pain. , 2008, Pain medicine.

[17]  K. Wells,et al.  Association between mental health disorders, problem drug use, and regular prescription opioid use. , 2006, Archives of internal medicine.

[18]  R. Portenoy,et al.  Opioid rotation: the science and the limitations of the equianalgesic dose table. , 2009, Journal of pain and symptom management.

[19]  Kent Nakamoto,et al.  Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. , 2009, The American journal on addictions.

[20]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[21]  R. Farney,et al.  Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[22]  Yongli Xi,et al.  Recent changes in drug poisoning mortality in the United States by urban–rural status and by drug type , 2008, Pharmacoepidemiology and drug safety.

[23]  B. Grant,et al.  Sleep-disordered breathing and chronic opioid therapy. , 2008, Pain medicine.

[24]  F. Baud,et al.  A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. , 2004, Addiction.